2023
DOI: 10.1021/acs.jmedchem.3c01322
|View full text |Cite
|
Sign up to set email alerts
|

High-Throughput Phenotypic Screening and Machine Learning Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic Agents

Pasquale Linciano,
Antonio Quotadamo,
Rosaria Luciani
et al.

Abstract: Broad-spectrum anti-infective chemotherapy agents with activity against Trypanosomes, Leishmania, and Mycobacterium tuberculosis species were identified from a high-throughput phenotypic screening program of the 456 compounds belonging to the Ty-Box, an in-house industry database. Compound characterization using machine learning approaches enabled the identification and synthesis of 44 compounds with broad-spectrum antiparasitic activity and minimal toxicity against Trypanosoma brucei, Leishmania Infantum, and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 64 publications
0
0
0
Order By: Relevance
“…Monocyclic and bicyclic aromatic systems such as pyrimidines, pteridines, quinolines, pyrrolo-pyrimidines, benzimidazoles, and benzothiazoles, mimicking the substrate pterin moiety, were extensively studied as molecular scaffolds for the design of Tb PTR1 and Tb DHFR inhibitors. , Also, the antimalarial drug cycloguanil (Cyc) (Figure a), featured by a dihydrotriazine core, was found to target Tb PTR1 besides Plasmodial and Trypanosoma DHFR . Interestingly, Cyc exhibited a superior affinity for Tb DHFR ( K i = 256 nM) than Tb PTR1 (IC 50 = 31.6 μM) and a low antiparasitic effect against T.…”
mentioning
confidence: 99%
“…Monocyclic and bicyclic aromatic systems such as pyrimidines, pteridines, quinolines, pyrrolo-pyrimidines, benzimidazoles, and benzothiazoles, mimicking the substrate pterin moiety, were extensively studied as molecular scaffolds for the design of Tb PTR1 and Tb DHFR inhibitors. , Also, the antimalarial drug cycloguanil (Cyc) (Figure a), featured by a dihydrotriazine core, was found to target Tb PTR1 besides Plasmodial and Trypanosoma DHFR . Interestingly, Cyc exhibited a superior affinity for Tb DHFR ( K i = 256 nM) than Tb PTR1 (IC 50 = 31.6 μM) and a low antiparasitic effect against T.…”
mentioning
confidence: 99%